Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BY 4.0Frontiers in Bioengineering and Biotechnology

Design and validation of nucleosome binding peptides using BindCraft

4 affiliations
  1. 1Department of Biology, Lomonosov Moscow State University, Moscow, Russia
  2. 2Department of Physics, Lomonosov Moscow State University, Moscow, Russia
  3. 3Institute of Gene Biology, Moscow, Russia
  4. 4Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, PA, United States

Abstract

Chromatin is a sophisticated assembly of DNA, RNA and proteins in the nuclei of eukaryotic cells. Protein-protein interactions that govern chromatin function are key regulators of genome activity, making them prime targets for drug discovery. Engineering and modulating these contacts presents a viable pathway for innovative epigenetic therapies. Nucleosomes, the primary structural units of chromatin, feature various interaction interfaces, most notably the acidic patch. This region serves as a critical binding site for numerous chromatin-associated proteins, often via their intrinsically disordered regions. Advances in AI-driven protein design have recently opened new avenues for the rational development of molecules aimed at modulating these chromatin interactions. In this research, we implemented an integrated computational and experimental framework to design and validate peptides targeting the nucleosome acidic patch. We relied on the AI protein design approach implemented in BindCraft to design nucleosome binding peptides. To achieve precise quantitative analysis of these interactions, we refined a donor FRET quenching assay specifically for this application, enabling sensitive and consistent measurement of binding affinities for the designed sequences. We successfully identified peptides with high affinity for the acidic patch on canonical nucleosome core particles. These findings highlight the potential of AI-assisted design for chromatin-targeting agents and establish an effective workflow for their validation, laying the groundwork for synthetic epigenetic modulators and the broader use of protein design in managing 3D genome organization.

Related

  1. G4 RNA inhibits PRC2 by sequestering two disordered loops required for nucleosome binding
    J. D. Houslay, N. Justin, R. G. Jenner +2
    bioRxivPreprintCC BYFull textBiophysicsbioRxiv
  2. Sequence-dependent binding modes of INO80 control +1 nucleosome positioning
    M. Likhodeeva, A. Brem, A. Lopez-Francos +9
    bioRxivPreprintCC BY-NC-NDFull textMolecular biology & gene regulationbioRxiv
  3. Laminin-Derived Peptides Bind Neuropilin-1 at the VEGF-A165 Binding Pocket
    E. Veltri, S. Lovas
    bioRxivPreprintCC BYFull textBiophysicsbioRxiv
  4. Identification of candidate HLA-E binding peptides from Mycobacterium tuberculosis using phage secretome library screening and computational modeling
    Nkanyezi Masondo, Michelle Lucille Gordon, Thamsanqa Emmanuel Chiliza
    Frontiers in Cellular and Infection MicrobiologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMC
  5. Affinity and Conformations of Ca2+-Calmodulin Bound to Peptides Containing the Calmodulin-Binding Motif of HIV-1 Matrix Protein
    Arvin Saffarian Delkhosh, Adeyemi Ogunbowale, Elaheh Hadadianpour +3
    bioRxivPreprintCC BY-NC-NDFull textBiophysicsbioRxivPMC
BibTeX
@article{oleinikov2026design,
  title = {{Design and validation of nucleosome binding peptides using BindCraft}},
  author = {Pavel D. Oleinikov and Grigoriy A. Armeev and Alina E. Sidorkina and Elizaveta B. Rykunova and Galina A. Komarova and Nikita A. Motorin and Nadezhda S. Gerasimova and Alexey V. Feofanov and Vasily M. Studitsky and Alexey K. Shaytan},
  journal = {Frontiers in Bioengineering and Biotechnology},
  year = {2026},
  month = oct,
  doi = {10.3389/fbioe.2026.1946220},
  url = {https://doi.org/10.3389/fbioe.2026.1946220},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Design and validation of nucleosome binding peptides using BindCraft
AU  - Pavel D. Oleinikov
AU  - Grigoriy A. Armeev
AU  - Alina E. Sidorkina
AU  - Elizaveta B. Rykunova
AU  - Galina A. Komarova
AU  - Nikita A. Motorin
AU  - Nadezhda S. Gerasimova
AU  - Alexey V. Feofanov
AU  - Vasily M. Studitsky
AU  - Alexey K. Shaytan
PY  - 2026
DA  - 2026/10/22
JO  - Frontiers in Bioengineering and Biotechnology
DO  - 10.3389/fbioe.2026.1946220
UR  - https://doi.org/10.3389/fbioe.2026.1946220
AB  - Chromatin is a sophisticated assembly of DNA, RNA and proteins in the nuclei of eukaryotic cells. Protein-protein interactions that govern chromatin function are key regulators of genome activity, making them prime targets for drug discovery. Engineering and modulating these contacts presents a viable pathway for innovative epigenetic therapies. Nucleosomes, the primary structural units of chromatin, feature various interaction interfaces, most notably the acidic patch. This region serves as a critical binding site for numerous chromatin-associated proteins, often via their intrinsically disordered regions. Advances in AI-driven protein design have recently opened new avenues for the rational development of molecules aimed at modulating these chromatin interactions. In this research, we implemented an integrated computational and experimental framework to design and validate peptides targeting the nucleosome acidic patch. We relied on the AI protein design approach implemented in BindCraft to design nucleosome binding peptides. To achieve precise quantitative analysis of these interactions, we refined a donor FRET quenching assay specifically for this application, enabling sensitive and consistent measurement of binding affinities for the designed sequences. We successfully identified peptides with high affinity for the acidic patch on canonical nucleosome core particles. These findings highlight the potential of AI-assisted design for chromatin-targeting agents and establish an effective workflow for their validation, laying the groundwork for synthetic epigenetic modulators and the broader use of protein design in managing 3D genome organization.
SN  - 2296-4185
ER  -